Cosentyx (secukinumab) is a prescription medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. According to Drugs.com [2], it is unknown whether Cosentyx passes into breast milk or not. Therefore, it is essential to take precautions while using this medication if you are breastfeeding.

The Cosentyx website [3] recommends consulting with a healthcare provider before using Cosentyx if you are pregnant or breastfeeding. They also suggest enrolling in the Cosentyx Connect Personal Support Program, which offers resources and support to patients using Cosentyx, including those who are breastfeeding.

Drug Patent Watch [1] indicates that there are no patents or exclusivities listed for Cosentyx, which suggests that the medication is available as a generic version. However, this information is not directly related to the precautions of Cosentyx and breastfeeding.

In summary, if you are breastfeeding and considering using Cosentyx, it is essential to consult with your healthcare provider before starting the medication. The Cosentyx website offers resources and support for patients, including those who are breastfeeding. As per Drugs.com, it is unknown whether Cosentyx passes into breast milk or not.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] https://www.drugs.com/breastfeeding/secukinumab.html
[3] https://www.cosentyx.com/cosentyx-connect-personal-support-program